Welcome to Growcorp

Growcorp is a leading integrated bioscience investment, advisory and incubation organisation, which delivers the resources to ensure success in the global marketplace.

Investment
Growcorp was the first private company in Ireland with an investment fund targeted specifically at the bioscience sector ("The European Bioscience Fund I").  Growcorp invests at an early stage in amounts up to Euro 1.27 Million and has led syndicates in excess of Euro 20 Million to take businesses to product launch.

Advisory
The Growcorp team works with entrepreneurs to get their business from start-up to commercial reality. We offer a range of services from strategy optimisation, IP exploitation to fund-raising and team building advice.

Incubation
Growcorp manages serviced office facilities which are suitable for a range of start-up companies and are available on flexible terms.


Investors information   
  TODAY'S NEWS



Copyright 2007 Growcorp Group. All Rights Reserved.
Office: Growcorp Group Limited, 3015 Lake Drive, Citywest Campus, Citywest, Dublin 24 | Telephone: +353 1 4661000 | Fax: +353 1 4661002
Site developed by 4wardwebdesign
"facilitating growth,     
                     together"
December 2008
Growcorp generates over Eur 7m following Neutekbio acquisition.

Galway and Dublin. Wednesday, 3rd December, 2008: Growcorp Group, the Irish investment vehicle, will earn over Eur 7m following the acquisition this week of Irish theranoistic company Neutekbio by Danish biotechnology development company Merrion Pharmaceuticals has signed a multi-million euro deal with Novo Nordisk to develop oral diabetes products.

Merrion Pharmaceuticals Receives 2008 Frost & Sullivan Osteoporosis Technology Innovation of the Year Award.

November 2008
Irish drug development company Merrion Pharmaceuticals has signed a multi-million euro deal with Novo Nordisk to develop oral diabetes products.

Merrion Pharmaceuticals Receives 2008 Frost & Sullivan Osteoporosis Technology Innovation of the Year Award.

September 2008
Merrion Pharmaceuticals the TCD based Irish American company has confirmed that it has begun a joint feasibility study on oral drug delivery with Swiss based multinational Ferring Pharmaceuticals.

July 2008
Merrion Pharmaceuticals today announced the continuation of an oral drug delivery research collaboration programme with Novo Nordisk. This follows on from the completion of several oral feasibility studies combining Merrion's Gastrointestinal Permeation Enhancement Technology (GIPET) oral drug delivery technology with Novo Nordisk compounds.        

December 2007
Merrion Pharmaceuticals Plc was admitted to the IEX today and commenced unconditional trading.

November 2006
Merrion Pharmaceuticals Ltd, Dublin, announced the successful conclusion of an €8m funding round which was oversubscribed, and was managed on behalf of the company by Goodbody Stockbrokers.

June 2006
Enterprise START Programme
As Enterprise Ireland are anxious to greatly increase the number of High Potential Start-Up Companies, this Programme is heavily subsidised (70%) resulting in a cost per participant of €275

April 2006
Merrion Pharma raises €5M ahead of 2007 float Dublin drugmaker Merrion Pharma has raised €5M in funding ahead of a dual stock market floatation

March 2006
Pharma Firm Merrion Hires Funding Adviser Merrion Pharmaceuticals will this week begin a fundraising roadshow in Dublin

October 2004
Maher appointed MD at bioscience investment specialist Growcorp Bioscience investment specialist Growcorp has appointed Fintan Maher as managing director.

September 2004
Biopharma Firm Plans Drug Launch
Trinity College based pharmaceuticals start-up Merrion Biopharma said yesterday that it was on track to introduce its products on to the $24 billion (€19.5 billion) oral drug delivery .........

July 2004
Investing in Ireland
From World Pharmaceutical Frontiers
The Republic of Ireland offers enormous potential to foreign investors for the pharmaceuticals, and particularly the biopharmaceuticals industry.

June 2004
17/06/2004 Funding of €20m now in sight for new pharma
A new specialty pharmaceutical company backed by the sons of entrepreneur Tony Ryan is close to receiving an estimated €20m-plus in venture capital funding.

06/06/2004 €1.8m funding could finance NeutekBio expansion
NeutekBio, the Galway biotechnology company, plans to expand and bank its first revenues by the end of the year after raising €1.8 million from investors.

01/06/2004 The Growcorp life sciences investment firm run by leading businessman Michael Donnelly, is planning to raise €50 million and …….

May 2004
30/05/2004 Growcorp in bid for €75m venture capital fund Growcorp, the life sciences investment firm, plans to raise a new €75 million venture capital fund.
May 2004 Ireland – Bio-Incubator Launched Dublin – Ireland is going to boost its biotech sector by investing in building up biotech incubators.

April 2004
April 2004 South Dublin Chamber of Commerce Year Book John Dunne Ex CEO – Personal Reflection
When I joined the Chamber it was in the process of extending …..

March 2004
27/03/2004 Elan Sells Projects to Start-Up
Elan has sold a drug-delivery research and development operation based at Trinity College to an Irish start-up, which recently secured $25 million (€20.6 million) in funding....

01/03/2004 Growcorp Establishes Drug Delivery & Biotechnology Company Adaptív Biopharma Limited (“Adaptiv”) is a company established by Growcorp to facilitate the acquisition and licensing of a number of technologies from Elan Corporation...

November 2002
11/13/2002 Tánaiste launches new €25 million bioscience fund
Mary Harney, Tánaiste and Minister for Enterprise, Trade and Employment, today launched the Growcorp €25 million European Bioscience Fund I – a new seed and venture capital fund...



  Growcorp
               Incorporated